Existence and significance of anti-HLA-C autoantibodies to primary and persistent platelet transfusion refractoriness in patients with hematologic disorders: a retrospective study from a single centre
This work emphasized the significance of anti-HLA-C autoantibody for P/P PTR in hematological patients, and rituximab may therapeutic.
Authors
- Yaonan Hong (ORCID: https://orcid.org/0000-0003-1146-0072)
- Dijiong Wu
- Baodong Ye (ORCID: https://orcid.org/0000-0001-5912-2633)
- Tonglin Hu
- Yuhong Zhou (ORCID: https://orcid.org/0000-0001-6333-8226)
- Hangchao Li (ORCID: https://orcid.org/0000-0002-7097-8667)
- Pan Wang (ORCID: https://orcid.org/0000-0002-9779-1878)
- Qi Liu
- Junfeng Guo
- Xiawan Yang (ORCID: https://orcid.org/0000-0002-2183-2741)
- Xunhua Li (ORCID: https://orcid.org/0000-0001-8679-1082)
- Jianping Shen (ORCID: https://orcid.org/0000-0002-9999-7482)
- Yiping Shen
- Shan Liu (ORCID: https://orcid.org/0000-0003-0159-0690)
- Chuanao Xin
- Ying‐Ying Shen
- Jingjie Dong
- Zexing Sun
Institutions
- Zhejiang Chinese Medical University (CN)
- Wenzhou Hospital of Traditional Chinese Medicine (CN)
- Blood Center of Zhejiang Province (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1080/07853890.2024.2446689
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- National Natural Science Foundation of China
- Zhejiang Medical Association